Pharmacovigilance (Safety Monitoring) Expense
Recording the ongoing cost of post-marketing drug safety surveillance and adverse event reporting.
| Account Name | Type | Debit ($) | Credit ($) |
|---|---|---|---|
| Pharmacovigilance Expense (R&D or SG&A) | Expense (+) | 1,800,000.00 | - |
| Accounts Payable / Accrued PV Costs | Liability (+) | - | 1,800,000.00 |
💡 Accountant's Note
After drug approval, manufacturers have a legal obligation to monitor product safety and report adverse events to regulatory authorities. Pharmacovigilance (PV) costs include safety database maintenance, signal detection, periodic safety reports, and literature monitoring. These are ongoing regulatory obligations — distinct from clinical trial monitoring. Classification as R&D or SG&A is an accounting policy choice.
Practitioner & Systems Framework
💻 ERP Architecture
Pharmacovigilance costs are tracked in a dedicated cost centre (or split between R&D and regulatory affairs depending on the company's organisational structure). PV activities include the safety database (Argus, ARISg, Oracle AERS), global literature monitoring, PSUR/PBRER preparation, signal detection and evaluation, and health authority correspondence. CRO partners for PV activities are billed monthly based on contracted service levels. The cost is accrued monthly based on PV activity levels. PV responsibilities are often included in commercialisation agreements and distribution partnerships — the allocation of PV cost between licensor and licensee is specified in the agreement.
⚠️ Audit Flags
Auditors confirm the expense classification policy (R&D vs. regulatory affairs / SG&A) is consistently applied. Test that PV costs relating to approved (commercial) products are not classified as clinical R&D. Review whether any PV activities are triggering clinical obligations (e.g., a post-marketing safety study required by the FDA as a condition of approval — REMS) — these should be provisioned as a contingent liability if not already accrued. Confirm that PV regulatory reporting obligations are being met — missed safety reports create regulatory and legal liability.
📄 Required Documentation
PV SOPs (Standard Operating Procedures), PV vendor agreements and monthly invoices, PV accrual methodology, expense classification policy (R&D vs. SG&A), post-marketing commitment schedule (FDA, EMA required studies), REMS programme cost budget, and regulatory submission calendar for PSDURs/PBRERs.
Professional Excel Template
Get the automated version of this entry. Includes built-in IFRS checks, VAT calculators, and SAP-ready upload formats.
Expert Analysis by Qusai Ahmad
General Accountant Supervisor & IFRS Specialist
Specialized in SAP GUI automation and Middle Eastern tax compliance. Building digital tools for the next generation of finance leaders.